Showing results (81-90 of 171) with videos related to

Sort By:
Pageof 18
International Journal of Hematology|August 24, 2012
High WT1 mRNA expression after induction chemotherapy and FLT3-ITD have prognostic impact in pediatric acute myeloid leukemia: a study of the Japanese Childhood AML Cooperative Study GroupAkira Shimada, Tomohiko Taki, Daisuke Koga, et al.
Haematologica|June 4, 2008
Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15Atsushi Manabe, Akira Ohara, Daisuke Hasegawa, et al.
Cancer Science|February 15, 2008
Whole-genome profiling of chromosomal aberrations in hepatoblastoma using high-density single-nucleotide polymorphism genotyping microarraysMakoto Suzuki, Motohiro Kato, Chen Yuyan, et al.
Cancer Science|October 15, 2021
C/EBPβ induces B-cell acute lymphoblastic leukemia and cooperates with BLNK mutationsMorito Kurata, Iichiro Onishi, Tomoko Takahara, et al.
Genes, Chromosomes & Cancer|March 29, 2002
Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumorsKaoru Uno, Junko Takita, Kinji Yokomori, et al.
Leukemia & Lymphoma|December 29, 2004
In vitro drug resistance to imatinib and mutation of ABL gene in childhood Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemiaHiroyuki Kawaguchi, Takeshi Taketani, Teruaki Hongo, et al.
International Archives of Allergy and Immunology|June 8, 2011
Eosinophilic gastrointestinal disorders in infants: a Japanese case seriesYoshiyuki Yamada, Akira Nishi, Yoshifumi Ebara, et al.
International Journal of Oncology|September 10, 2003
Aberrations of p16INK4A, p14ARF and p15INK4B genes in pediatric solid tumorsKazuko Obana, Hong-Wei Yang, Hui-Ying Piao, et al.
Nucleic Acids Research|March 9, 2013
An empirical Bayesian framework for somatic mutation detection from cancer genome sequencing dataYuichi Shiraishi, Yusuke Sato, Kenichi Chiba, et al.
Cancer Science|June 26, 2026
A Three-Dimensional Culture-Drug Sensitivity Test Predicts MDM2 Inhibitor-Sensitivity in SMARCB1/INI1-Deficient TumorsHiroaki Goto, Chiyoko Nishime, Takashi Ohtsu, et al.
Pageof 18